Importantly, in vitro studies have shown heterogeneity with regards to which anti-apoptotic Bcl-2-family proteins MM cells are dependent on, which further complicates the ideal utilization of Bcl-2-family inhibitors in RRMM. Here, BCL2 is linked to Miyoshi myopathy.